We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Google AI System Beats Doctors in Detecting Breast Cancer

By HospiMedica International staff writers
Posted on 06 Jan 2020
A team of researchers from Google Health (Palo Alto, CA, USA) have developed an artificial intelligence (AI) model which can spot breast cancer in de-identified screening mammograms (where identifiable information has been removed) with greater accuracy, fewer false positives, and fewer false negatives than experts. More...
This can find future applications wherein the model could support radiologists performing breast cancer screenings.

Despite the wide use of digital mammography, or X-ray imaging of the breast, to screen for breast cancer, spotting and diagnosing the disease early remains a challenge even for experts, and can often result in both false positives and false negatives. Such inaccuracies can lead to delays in detection and treatment, unnecessary stress for patients and a higher workload for radiologists who are already in short supply.

Over the last two years, Google Health has been working with leading clinical research partners in the UK and US to see if AI can improve the detection of breast cancer by supporting radiologists to spot the signs of breast cancer more accurately. The researchers trained and tuned the AI model on a representative data set comprised of de-identified mammograms from more than 76,000 women in the UK and 15,000 women in the US to see if it could learn to spot signs of breast cancer in the scans. They went on to evaluate the model on a separate de-identified data set of more than 25,000 women in the UK and 3,000 women in the US In this evaluation, the model produced a 5.7% reduction of false positives in the US and a 1.2% reduction in the UK. It produced a 9.4% reduction in false negatives in the US and a 2.7% reduction in the UK.

In order to see if their model could generalize to other healthcare systems, the researchers trained it only on the data from the women in the UK and then evaluated it on the data set from women in the US. In this separate experiment, there was a 3.5% reduction in false positives and an 8.1% reduction in false negatives, indicating the model’s potential to generalize to new clinical settings while still performing at a higher level than experts. Despite the model only processing the most recent anonymized mammogram and receiving less information than human experts who had access to patient histories and prior mammograms, it surpassed individual experts in accurately identifying breast cancer.

Related Links:
Google Health


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Isolation Stretcher
IS 736
Silver Member
ECG Management System
NEMS Web
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.